[Early-onset familial Alzheimer's disease with spastic paraparesis associated with PSEN1 gene]. 2023

G E Rudenskaya, and M S Petukhova, and V V Zabnenkova, and T B Cherevatova, and O P Ryzhkova
Research Centre for Medical Genetics, Moscow, Russia.

A familial case of a rare autosomal dominant Alzheimer's disease (AD), related to PSEN1 gene (AD3, OMIM 607822), differing from common multifactorial form by earlier onset and, in part of cases, by accompanying neurological signs, spastic paraparesis particularly, is presented. The first sign in a female proband and in her son was paraparesis manifested at the age of 29 and 21 years, respectively. Cognitive disturbances developed soon; the former diagnosis was hereditary spastic paraplegia with cognitive impairment, In the proband examined in 2008 at 33 years old the diagnosis was not established. In the son examined in 2022 at 27 years old whole-exome sequencing detected a novel PSEN1 missense mutation p.Thr421Ala. The mutation was confirmed by Sanger sequencing in him, found out in the proband (who was severely disabled by that time) and excluded in her unaffected mother. Except for different age of onset, AD3 in two patients was similar, though in whole it is variable, also in relatives. The variability and rareness of the disease hampers clinical diagnostics. Massive parallel sequencing is a most reliable diagnostic method.

UI MeSH Term Description Entries
D008297 Male Males
D009035 Mothers Female parents, human or animal. Mothers' Clubs,Club, Mothers',Clubs, Mothers',Mother,Mother Clubs,Mother's Clubs,Mothers Clubs,Mothers' Club
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010375 Pedigree The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition. Family Tree,Genealogical Tree,Genealogic Tree,Genetic Identity,Identity, Genetic,Family Trees,Genealogic Trees,Genealogical Trees,Genetic Identities,Identities, Genetic,Tree, Family,Tree, Genealogic,Tree, Genealogical,Trees, Family,Trees, Genealogic,Trees, Genealogical
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D017668 Age of Onset The age, developmental stage, or period of life at which a disease or the initial symptoms or manifestations of a disease appear in an individual. Age-at-Onset,Age at Onset,Onset Age
D053764 Presenilin-1 Integral membrane protein of Golgi and endoplasmic reticulum. Its homodimer is an essential component of the gamma-secretase complex that catalyzes the cleavage of membrane proteins such as NOTCH RECEPTORS and AMYLOID BETA-PEPTIDES precursors. PSEN1 mutations cause early-onset ALZHEIMER DISEASE type 3 that may occur as early as 30 years of age in humans. Presenilin 1,S182 Protein

Related Publications

G E Rudenskaya, and M S Petukhova, and V V Zabnenkova, and T B Cherevatova, and O P Ryzhkova
August 2007, Neuroreport,
G E Rudenskaya, and M S Petukhova, and V V Zabnenkova, and T B Cherevatova, and O P Ryzhkova
May 2011, Neuroscience letters,
G E Rudenskaya, and M S Petukhova, and V V Zabnenkova, and T B Cherevatova, and O P Ryzhkova
January 2008, Alzheimer disease and associated disorders,
G E Rudenskaya, and M S Petukhova, and V V Zabnenkova, and T B Cherevatova, and O P Ryzhkova
January 2009, American journal of Alzheimer's disease and other dementias,
G E Rudenskaya, and M S Petukhova, and V V Zabnenkova, and T B Cherevatova, and O P Ryzhkova
September 2007, Journal of the neurological sciences,
G E Rudenskaya, and M S Petukhova, and V V Zabnenkova, and T B Cherevatova, and O P Ryzhkova
January 2021, Alzheimer's & dementia (Amsterdam, Netherlands),
G E Rudenskaya, and M S Petukhova, and V V Zabnenkova, and T B Cherevatova, and O P Ryzhkova
January 2010, Neurologia (Barcelona, Spain),
G E Rudenskaya, and M S Petukhova, and V V Zabnenkova, and T B Cherevatova, and O P Ryzhkova
October 2001, Journal of neurology, neurosurgery, and psychiatry,
G E Rudenskaya, and M S Petukhova, and V V Zabnenkova, and T B Cherevatova, and O P Ryzhkova
February 2020, Scientific reports,
G E Rudenskaya, and M S Petukhova, and V V Zabnenkova, and T B Cherevatova, and O P Ryzhkova
August 2019, BMC neurology,
Copied contents to your clipboard!